Parameta produced 18% of TP ICAP’s adjusted EBIT from 8% of revenue—then Q3 growth stalled

TP ICAP’s data business generated a disproportionate share of first-half profit from a small share of group revenue. Parameta Solutions reported £102 million of revenue and £36 million of adjusted EBIT in the six months to June 2026. The group reported £1.292 billion of revenue and £196 million of adjusted EBIT. On those disclosed totals, Parameta supplied 7.9% of revenue but 18.4% of adjusted EBIT. Its 35.3% adjusted EBIT margin was 2.32 times the group’s 15.2%. The figures identify a high-margin asset inside a business still dominated by broking revenue.[2][3]

The third quarter interrupted the simple growth narrative. TP ICAP said Parameta’s year-to-date revenue was up 4% in constant currency, but Q3 revenue was flat at constant currency and down 2% on a reported basis. The company attributed the quarterly result partly to a decline in inter-division revenue following a one-off benefit in the prior year. Annual recurring revenue still grew 5%, and the group said it signed its largest new-logo US buy-side contract after the period. The division therefore combined strong margin quality with a visible quarterly slowdown.[1]

The profit share is real but not perfectly additive

The 18.4% calculation uses Parameta’s £36 million adjusted EBIT divided by the group’s £196 million adjusted EBIT. It is a useful measure of economic weight, but segment and group figures are not always perfectly additive. Corporate costs, eliminations and central items can sit outside the segment. The H1 materials recorded £20 million of intercompany eliminations in the revenue bridge. The ratio should therefore be read as Parameta’s disclosed adjusted EBIT relative to the disclosed group total, not as proof that exactly 18.4 pence of every group profit pound originated from external data customers.[2][3]

Parameta’s own first-half bridge shows £44 million of contribution before £8 million of support costs, leaving £36 million of adjusted EBIT. Contribution was 43.1% of revenue. That is a high conversion rate for a business built around pricing, reference and analytics products derived from market activity. Once data is collected, normalised, licensed and delivered, an additional subscription can carry less incremental cost than arranging another voice or electronic transaction. This operating leverage helps explain why the EBIT share exceeds the revenue share.[2][3]

The group comparison also reflects the lower margins of broking. Interdealer and agency execution businesses incur front-office compensation, venue, connectivity, regulatory and settlement-related costs tied more directly to activity. A data licence can recur without replicating the full transaction workflow. The contrast does not make broking economically unimportant: the underlying broker network is one source of the market information Parameta commercialises. The two businesses are connected even when their margins differ.[2]

External and internal revenue answer different questions

The H1 disclosure split Data & Analytics revenue into £97 million external and £5 million inter-division. External revenue grew 8% in constant currency, while inter-division revenue fell 17%. The total therefore understated the external growth rate because the smaller internal line moved in the opposite direction. Q3’s flat total was again affected by the prior-year one-off in inter-division revenue. A reader assessing customer demand should not treat an internal allocation as equivalent to a lost third-party contract.[1][3]

At the same time, internal revenue is not meaningless. It records value transferred within the group for data or services used by other divisions and can influence segment profitability. A one-off internal benefit can make a prior quarter’s comparison unusually demanding. The correct approach is to show both the consolidated effect—internal transactions eliminate at group level—and the segment effect—Parameta’s reported revenue and margin can move because of them.[1][3]

Annual recurring revenue provides another lens. TP ICAP said Parameta’s ARR increased 5% year on year. ARR is a run-rate measure, not revenue earned under accounting standards during the quarter. It can include contracted recurring amounts that will be recognised over time and may exclude transactional or non-recurring income. The 5% figure supports continuing subscription momentum, but it cannot be added to Q3 revenue or used as proof that every contract renewed without pricing concessions.[1]

A large contract does not repair the reported quarter yet

The company disclosed that Parameta signed its largest US buy-side new-logo contract after the quarter ended. That is a potentially important commercial event, especially for expansion beyond the traditional dealer customer base. But it occurred after the reported period and the release did not state contract value, term, implementation timetable or revenue-recognition profile. It should be described as evidence of pipeline conversion, not included retroactively in Q3 growth.[1]

The contract may also require onboarding, data entitlements and client integration before revenue reaches a steady run rate. Large data agreements can contain minimums, usage components, phased products and termination rights. Without the contract terms, neither total contract value nor annual recurring revenue can be calculated. The next results should show whether the win changes ARR growth or offsets the internal-revenue comparison.[1]

Q3’s flat constant-currency result also needs the right comparator. The group’s year-to-date revenue reached £1.912 billion, up 9% in constant currency, and Q3 group revenue rose 11% to £620 million. Parameta therefore underperformed the group’s quarterly growth, but it did not contract on the company’s constant-currency basis. “Stalled” describes the zero growth rate, not a collapse in demand or profitability.[1]

The strategic value lies in quality and independence

A data division that supplies nearly one-fifth of adjusted EBIT from less than one-tenth of revenue can materially influence valuation. High recurring revenue, pricing power and low marginal distribution cost often attract higher multiples than cyclical brokerage. Yet the value also depends on data rights, customer concentration, regulatory permissions and whether products can grow independently of the transaction network that creates the underlying information. The public results establish margin; they do not disclose every dependency.[1][2]

Parameta’s external growth and buy-side expansion are therefore more important than total segment growth alone. A division that relies heavily on internal allocations or a small set of dealer customers may be less independent than its headline margin suggests. The H1 split—£97 million external against £5 million internal—shows that most revenue was already external. The Q3 one-off comparison nevertheless demonstrates that the small internal line can still distort short-period growth rates.[1][3]

The next useful evidence would include customer retention, net revenue retention, price versus volume, top-customer concentration, buy-side revenue and the value of the new US contract. It would also clarify support-cost allocation and show whether the 35.3% margin is sustained as the product and sales base expands. Growth that requires disproportionate sales, cloud or licensing expense could reduce the current conversion advantage; successful scaling could increase it.[1][2]

Capital intensity is another missing denominator. A high adjusted EBIT margin does not by itself establish a high return on capital if the division depends on substantial technology, data rights, regulatory infrastructure or group resources that are allocated elsewhere. Conversely, a data operation using intellectual property and systems already embedded in the group may require little incremental balance sheet. TP ICAP’s segment disclosure supports the revenue and EBIT comparison, but a full economic-return analysis would need invested capital, capitalised development, lease and central-technology allocations that are not presented in the quarterly growth statement.[2][3]

The documented conclusion is strong but bounded. Parameta represented only 7.9% of TP ICAP’s first-half revenue yet 18.4% of adjusted EBIT, with a margin more than twice the group level. Its external business grew, but total Q3 revenue was flat at constant currency after an inter-division prior-year benefit fell out of the comparison. The division is a high-margin contributor whose quarterly momentum needs to be read through internal allocations, recurring-revenue measures and the timing of new contracts.[1][2][3]

A more complete profitability bridge would separate subscription and usage revenue, internal group charges, data-acquisition costs and investment in new products. Parameta’s high margin can reflect the scalability of licensed data, but the group accounts do not show how much infrastructure, distribution or client access is shared with TP ICAP’s broking businesses. Nor does flat third-quarter revenue establish a structural slowdown when contract timing can move growth between quarters. The present calculation is therefore a segment-contribution finding: Parameta generated an outsized share of adjusted EBIT from a small revenue base. The durability question depends on external recurring growth and on whether the division can preserve that margin as product development and regulatory-data obligations expand.[1][2][3]

Report an error or submit an update